ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti-PD-1-Resistant Advanced Melanoma.

Alexander N Shoushtari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.